JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/26 | 1,362.5 | 1,369.5 | 1,334.5 | 1,338 | -43 | -3.1% | 386,500 |
2023/09/25 | 1,366 | 1,437.5 | 1,358 | 1,381 | +32 | +2.4% | 657,700 |
2023/09/22 | 1,342.5 | 1,365.5 | 1,329.5 | 1,349 | -10 | -0.7% | 306,600 |
2023/09/21 | 1,388 | 1,388 | 1,348.5 | 1,359 | -46.5 | -3.3% | 488,200 |
2023/09/20 | 1,432 | 1,441 | 1,400 | 1,405.5 | -46.5 | -3.2% | 473,000 |
2023/09/19 | 1,426 | 1,458.5 | 1,421 | 1,452 | +6 | +0.4% | 573,100 |
2023/09/15 | 1,389.5 | 1,455 | 1,381.5 | 1,446 | +59 | +4.3% | 768,000 |
2023/09/14 | 1,384 | 1,403.5 | 1,345 | 1,387 | -17 | -1.2% | 589,800 |
2023/09/13 | 1,324 | 1,410 | 1,313.5 | 1,404 | +106.5 | +8.2% | 1,120,100 |
2023/09/12 | 1,239.5 | 1,318 | 1,239.5 | 1,297.5 | +56.5 | +4.6% | 531,500 |
2023/09/11 | 1,241.5 | 1,258.5 | 1,226 | 1,241 | +15.5 | +1.3% | 249,300 |
2023/09/08 | 1,213 | 1,239.5 | 1,210 | 1,225.5 | +8.5 | +0.7% | 330,700 |
2023/09/07 | 1,234 | 1,237 | 1,216.5 | 1,217 | -32 | -2.6% | 321,800 |
2023/09/06 | 1,250 | 1,267 | 1,244 | 1,249 | -15 | -1.2% | 346,400 |
2023/09/05 | 1,269.5 | 1,292.5 | 1,259.5 | 1,264 | -6 | -0.5% | 277,300 |
2023/09/04 | 1,269 | 1,279 | 1,262 | 1,270 | +1.5 | +0.1% | 257,300 |
2023/09/01 | 1,271 | 1,279.5 | 1,259.5 | 1,268.5 | -7.5 | -0.6% | 233,100 |
2023/08/31 | 1,266.5 | 1,284 | 1,235 | 1,276 | +8.5 | +0.7% | 394,600 |
2023/08/30 | 1,289.5 | 1,289.5 | 1,267 | 1,267.5 | -15 | -1.2% | 271,400 |
2023/08/29 | 1,247.5 | 1,297.5 | 1,241.5 | 1,282.5 | +45.5 | +3.7% | 439,700 |
2023/08/28 | 1,245 | 1,264.5 | 1,236 | 1,237 | +1.5 | +0.1% | 247,500 |
2023/08/25 | 1,215 | 1,254.5 | 1,204 | 1,235.5 | +5.5 | +0.4% | 340,500 |
2023/08/24 | 1,217.5 | 1,240 | 1,204.5 | 1,230 | +12 | +1% | 402,900 |
2023/08/23 | 1,201 | 1,218 | 1,192.5 | 1,218 | +20.5 | +1.7% | 318,800 |
2023/08/22 | 1,199 | 1,217 | 1,175 | 1,197.5 | -9.5 | -0.8% | 323,500 |
2023/08/21 | 1,153 | 1,213 | 1,152.5 | 1,207 | +55 | +4.8% | 496,600 |
2023/08/18 | 1,160 | 1,162.5 | 1,142.5 | 1,152 | -18.5 | -1.6% | 337,800 |
2023/08/17 | 1,199 | 1,199 | 1,161 | 1,170.5 | -39 | -3.2% | 401,200 |
2023/08/16 | 1,240 | 1,242 | 1,204.5 | 1,209.5 | -43 | -3.4% | 397,000 |
2023/08/15 | 1,275 | 1,275 | 1,247.5 | 1,252.5 | -22.5 | -1.8% | 265,600 |
2023/08/14 | 1,268 | 1,292.5 | 1,259 | 1,275 | +8 | +0.6% | 274,100 |
2023/08/10 | 1,269.5 | 1,285 | 1,245.5 | 1,267 | -20 | -1.6% | 275,200 |
2023/08/09 | 1,278 | 1,293 | 1,260.5 | 1,287 | +0.5 | ±0% | 261,300 |
2023/08/08 | 1,297.5 | 1,305 | 1,274 | 1,286.5 | -11 | -0.8% | 332,800 |
2023/08/07 | 1,262 | 1,300 | 1,235.5 | 1,297.5 | +19 | +1.5% | 478,200 |
2023/08/04 | 1,326 | 1,326 | 1,262.5 | 1,278.5 | -49.5 | -3.7% | 524,300 |
2023/08/03 | 1,368.5 | 1,370.5 | 1,320 | 1,328 | -41.5 | -3% | 504,900 |
2023/08/02 | 1,353 | 1,382.5 | 1,340 | 1,369.5 | -8.5 | -0.6% | 570,500 |
2023/08/01 | 1,350 | 1,379 | 1,336 | 1,378 | +28 | +2.1% | 646,800 |
2023/07/31 | 1,382 | 1,382 | 1,340 | 1,350 | -17 | -1.2% | 795,800 |
2023/07/28 | 1,386 | 1,393.5 | 1,326 | 1,367 | -16.5 | -1.2% | 880,000 |
2023/07/27 | 1,400 | 1,433 | 1,306.5 | 1,383.5 | +66.5 | +5% | 2,371,000 |
2023/07/26 | 1,237.5 | 1,317 | 1,217.5 | 1,317 | +88 | +7.2% | 918,000 |
2023/07/25 | 1,214 | 1,249.5 | 1,207 | 1,229 | +9 | +0.7% | 561,600 |
2023/07/24 | 1,255 | 1,255 | 1,211.5 | 1,220 | -35 | -2.8% | 669,300 |
2023/07/21 | 1,250 | 1,257.5 | 1,234 | 1,255 | +5 | +0.4% | 293,700 |
2023/07/20 | 1,246 | 1,254.5 | 1,229.5 | 1,250 | +4 | +0.3% | 399,200 |
2023/07/19 | 1,247.5 | 1,259 | 1,237 | 1,246 | +2.5 | +0.2% | 382,100 |
2023/07/18 | 1,253 | 1,255.5 | 1,231 | 1,243.5 | -6 | -0.5% | 417,800 |
2023/07/14 | 1,260 | 1,266.5 | 1,237 | 1,249.5 | -7 | -0.6% | 313,200 |
151~
200
件表示中 / 6706件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 64,800円 | +32.2% | +84.6% | 3.09% | 11.08倍 | 1.45倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
鳥居薬 | 395,500円 | +7.3% | +16.8% | 3.03% | 23.65倍 | 0.93倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
ゼリア新薬 | 203,500円 | +9.6% | +17.5% | 2.26% | 11.50倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
栄研化 | 206,500円 | +7.6% | +57.5% | 2.57% | 15.95倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割弱。尿検査(ウロ)、遺伝子検査も育成 |
あすかHD | 246,300円 | +2.6% | +5.1% | 1.62% | 11.26倍 | 1.19倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム